Article
The tumor therapy landscape of synthetic lethality.
Nature communications - 24 Feb 2021
Zhang Biyu, Tang Chen, Yao Yanli, Chen Xiaohan, Zhou Chi, Wei Zhiting, Xing Feiyang, Chen Lan, Cai Xiang, Zhang Zhiyuan, Sun Shuyang, Liu Qi
Abstract excerpt
Synthetic lethality is emerging as an important cancer therapeutic paradigm, while the comprehensive selective treatment opportunities for various tumors have not yet been explored. We develop the Synthetic Lethality Knowledge Graph (SLKG), presenting the tumor therapy landscape of synthetic lethality (SL) and synthetic dosage lethality (SDL). SLKG integrates the large-scale entity of different tumors, drugs and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
